Non-adherence to prescriptions is costly. Not only does it lead to poor health outcomes for patients, but it also leads to missed opportunities for pharmaceutical companies. These factors, combined with the growing opioid crisis, mean that the FDA will be implementing new requirements in the packaging of drugs, beginning with opiates.  In the wake of these changes, decision makers will be forced to adjust packaging to meet new standards.

Download this playbook to receive unique insights from WestRock, one of the leading manufacturers in customized packaging who collaborated directly with the FDA in creating their designs.

In this playbook we discuss:

• How innovative packaging designs improve patient adherence
• An overview of upcoming FDA regulations for prescription packaging and distribution
• The cost-related benefits of getting ahead of new FDA packaging regulations